日本語 >>
TOP page
Presentation
（Last updated : 2021-03-03 10:07:03）
長洲 晶子
Department
,
Position
■
Journal
1.
2019/08
Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome
2.
2019/04
Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Faslpr Mice.
3.
2018/01
Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
4.
2015/12
Arthritis in a patient with Takayasu arteritis
5.
2013/10
Spontaneous splenic rupture complicating granulomatosis with polyangiitis (Wegener's)
6.
2013/08
Predominance of Th2 and regulatory cytokines in the serum of a patient with IgG4-related lymphadenopathy
7.
2012/04
Mesenteric panniculitis: a rare cause of fever
Display 5 items
Display all(7)
■
Presentation
1.
2020/12/04
The role of an adaptor protein SH3BP2 in the pathogenesis of systemic lupus erythematosus
2.
2020/11/07
SH3BP2 Deciency Ameliorates Murine Systemic Lupus Erythematosus
3.
2020/10/24
SH3BP2 deficiency ameliorates murine systemic lupus erythematosus
4.
2020/07/08
全身性エリテマトーデスモデルマウスにおけるアダプター蛋白SH3BP2 の自己免疫現象における役割の解明
5.
2019/11/10
The role of adopter protein SH3BP2 in a murine systemic lupus erythematosus model
6.
2019/11/10
The Study of the Novel G87V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
7.
2019/04/17
SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice
8.
2019/04/16
The Study of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome(TRAPS)
9.
2018/10/21
The novel G58V mutation in the TNFRSF1A gene identified in a family with TNF Receptor-Associated Periodic Syndrome (TRAPS) decreases the cell surface expression of TNFR1
10.
2018/04/27
Bone systemic administration of angiotensin II and its type 1 receptor gene deletion exacerbates erosive bone destruction in hTNF-transgenic arthritis mice
11.
2018/04/27
Myostatin inhibition reduces bone loss in an unloading osteoporosis model
12.
2018/04/27
Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastgenesis
13.
2018/04/27
SH3BP2 gain-of-function mutation alleviates lupus phenotypes in B6.MRL-Faslpr mice
14.
2018/04/26
Functional analysis of the novel G58V mutation in the TNFRSF1A gene identified in a family with TNF receptor-associated periodic syndrome(TRAPS)
15.
2017/11/07
SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice
16.
2017/11/06
Angiotensin II Type I Receptor Deficiency Exacerbates Erosive Bone Destruction ofhTNF-Transgenic Arthritis Mice
17.
2017/11/05
Functional Analysis of the Novel G58V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
18.
2017/11/05
Tankyrase/Wnt Inhibitor Upregulates Osteoclastogenesis and Osteoblastogenesis Via
SH3BP2
19.
2017/11/05
The Effect of Myostatin Inhibition on Bone Loss in Murine Osteoporosis Models
20.
2017/04/21
Tankyrase regulates bone mass and osteoclastogenesis
21.
2017/04/20
Angiotensin II exacerbates bone destruction in human TNF-transgenic arthritis mice
22.
2017/04/20
The effect of myostatin inhibition on bone loss in murine osteoporosis models
23.
2016/11/14
Tankyrase Regulates Osteoclastogenesis Via SH3BP2
24.
2016/11/13
Angiotensin II Exacerbates Bone Destruction in TNF-Transgenic Arthritis Mice
25.
2016/04/23
Tankyrase Inhibitor Promotes Osteoclastogenesis by Enhancing SH3BP2 expression
26.
2015/11/16
Tankyrase regulates osteoclastogenesis via SH3BP2 expression
Display 5 items
Display all(26)
